Search

everythinglearnresearchcommunity

for

Search:↓

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Using cidofovir cream for a rare skin disease can cause skin darkening.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Low power red laser with efavirenz can reduce HIV-1 infection to undetectable levels and improve diagnosis.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

TB and BCC tumors show similar follicular differentiation patterns.

ABCG2 protein marks stem-like skin cells in human epidermis.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Controlling Tslp can improve health in AEC syndrome patients.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Belatacept may be a promising treatment for alopecia areata.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Lack of Vitamin D receptor changes skin structure and increases certain immune cells in the skin.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

A mix of specific inhibitors and a growth factor helps keep hair growth cells from losing their properties in the lab.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.